Research Portal

U.S.-listed market research with live data and structured thesis notes.

Powered by AI

Your AI Research
Copilot for Markets

Real-time market intelligence, structured thesis notes, and AI-driven analysis — all in one place.

AI Research Assistant
Side-by-side research view

Compare names across metrics and research quality

Use up to 4 U.S.-listed names from this dashboard to compare valuation, growth, cash flow, balance-sheet strength, and the curated investment case in one place.

1 stocks in current compare
4 max names side by side
24 shared metrics lined up

Build a compare set

Enter comma-separated tickers from the dashboard universe. Duplicate tickers are ignored automatically.

Clear
Compute Stack AI Platforms Power Buildout Robotics
SYK Robotics

Stryker

Orthopedic robotics platform

Detail page

Stryker's Mako franchise makes it one of the clearest scaled robotics names in orthopedics.

Price $321.49
1D change +1.18%
Market cap $123.25B
Sector Healthcare

Shared metric table

Live market metrics plus reported quarterly revenue and profit QoQ rows.

Green and red only apply where direction is meaningful. Quarterly revenue and profit cells inherit the sign of the reported QoQ change, which can swing sharply when the prior quarter included a one-time item.

On smaller screens, swipe this table horizontally to compare the full set.

Metric SYK
Price $321.49
1D Change +1.18%
Market Cap $123.25B
Enterprise Value $135.52B
Trailing P/E 36.8
Forward P/E 19.2
Price / Sales 4.9
EV / Revenue 5.4
Revenue Growth 2.6%
Earnings Growth 14.2%
Gross Margin 64.7%
Operating Margin 17.8%
Net Margin 13.2%
ROE 15.2%
Free Cash Flow $4.36B
FCF Margin 17.3%
Debt / Equity 0.66x
Current Ratio 2.11x
Dividend Yield 109.00%
Next Earnings Jul 30, 2026
Quarterly Revenue $6.02B
Revenue QoQ -16.1%
Quarterly Net Income $745.0M
Net Income QoQ -12.2%

SYK thesis lens

Orthopedic robotics platform

Why it could benefit

  • Stryker's Mako franchise makes it one of the clearest scaled robotics names in orthopedics.
  • Recent expansion into handheld robotics broadens the Mako platform and gives the sleeve another real medical-robotics leader.
  • It adds exposure to hospital robotics without relying on the exact same thesis as Intuitive.

Moat / edge

  • Established Mako installed base and surgeon workflow integration.
  • Strong orthopedic distribution and clinical relationships.
  • A robotics platform that can expand across procedures over time.

What to watch

  • Mako placements and utilization.
  • Adoption of new handheld robotics offerings.
  • How much robotics continues to differentiate Stryker in orthopedics.

Key risks

  • Hospital budgets and elective procedure trends can affect demand.
  • The robotics narrative is important, but it still sits inside a broader medtech company.